Veracyte Quarterly Balance Sheets Chart
Quarterly
|
Annual
Veracyte Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-06-30 | 2014-03-31 | 2013-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 219,499,000 | 186,120,000 | 239,087,000 | 274,079,000 | 235,915,000 | 209,188,000 | 216,454,000 | 202,463,000 | 191,142,000 | 177,890,000 | 154,247,000 | 170,112,000 | 153,447,000 | 163,615,000 | 173,197,000 | 164,029,000 | 327,545,000 | 324,062,000 | 349,364,000 | 345,080,000 | 147,450,000 | 153,132,000 | 159,317,000 | 195,662,000 | 192,647,000 | 67,841,000 | 77,995,000 | 77,846,000 | 23,758,000 | 27,152,000 | 33,891,000 | 41,195,000 | 46,463,000 | 51,506,000 | 59,219,000 | 31,699,000 | 38,993,000 | 47,456,000 | 46,116,000 | 51,045,000 | 25,798,000 | 57,998,000 | 64,237,000 | 15,426,000 |
short-term investments | 101,220,000 | 101,235,000 | 50,354,000 | 24,605,000 | 10,551,000 | |||||||||||||||||||||||||||||||||||||||
accounts receivable | 50,814,000 | 53,781,000 | 46,525,000 | 48,807,000 | 50,304,000 | 46,665,000 | 40,378,000 | 39,297,000 | 42,365,000 | 45,489,000 | 44,021,000 | 40,068,000 | 40,448,000 | 42,481,000 | 41,461,000 | 40,309,000 | 31,864,000 | 27,877,000 | 18,461,000 | 17,629,000 | 15,306,000 | 19,091,000 | 19,329,000 | 23,613,000 | 19,626,000 | 16,615,000 | 13,168,000 | 12,262,000 | 13,006,000 | 13,198,000 | 12,716,000 | 11,635,000 | 11,027,000 | 9,125,000 | 8,756,000 | 6,312,000 | 3,387,000 | 3,230,000 | 3,520,000 | 3,586,000 | 2,564,000 | 1,430,000 | 1,191,000 | 714,000 |
supplies and inventory | 25,020,000 | 24,254,000 | 21,750,000 | 20,364,000 | 19,258,000 | 18,328,000 | 16,128,000 | 15,887,000 | 11,572,000 | 13,306,000 | 14,294,000 | 13,798,000 | 14,600,000 | 12,372,000 | ||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 18,128,000 | 17,762,000 | 14,551,000 | 13,604,000 | 15,629,000 | 16,237,000 | 12,661,000 | 13,516,000 | 14,401,000 | 14,818,000 | 11,469,000 | 14,538,000 | 15,999,000 | 20,015,000 | 17,219,000 | 15,146,000 | 5,263,000 | 3,845,000 | 3,197,000 | 3,150,000 | 2,891,000 | 3,045,000 | 2,235,000 | 2,196,000 | 2,573,000 | 2,392,000 | 2,387,000 | 1,803,000 | 1,822,000 | 2,142,000 | 1,997,000 | 1,617,000 | 1,933,000 | 2,101,000 | 2,057,000 | 1,405,000 | 1,395,000 | 1,618,000 | 3,371,000 | 1,735,000 | 1,179,000 | 1,450,000 | 1,014,000 | 2,938,000 |
total current assets | 414,681,000 | 383,152,000 | 372,267,000 | 356,854,000 | 321,106,000 | 290,418,000 | 285,621,000 | 271,163,000 | 259,480,000 | 251,503,000 | 248,636,000 | 238,516,000 | 235,045,000 | 238,483,000 | 243,102,000 | 229,308,000 | 371,346,000 | 362,092,000 | 375,679,000 | 370,315,000 | 172,688,000 | 181,362,000 | 187,687,000 | 228,079,000 | 219,950,000 | 90,616,000 | 96,952,000 | 95,374,000 | 41,635,000 | 47,049,000 | 53,928,000 | 58,207,000 | 62,860,000 | 66,295,000 | 73,627,000 | 42,952,000 | 47,397,000 | 56,194,000 | 57,331,000 | 60,714,000 | 33,691,000 | 64,178,000 | 69,163,000 | 20,470,000 |
property, plant and equipment | 18,552,000 | 22,529,000 | 22,953,000 | 21,194,000 | 22,291,000 | 21,566,000 | 20,584,000 | 19,288,000 | 18,510,000 | 18,072,000 | ||||||||||||||||||||||||||||||||||
right-of-use assets, operating leases | 38,679,000 | 47,624,000 | 48,189,000 | 17,031,000 | 18,116,000 | 11,167,000 | 10,277,000 | 11,297,000 | 12,455,000 | 11,308,000 | 13,885,000 | 14,816,000 | 15,663,000 | |||||||||||||||||||||||||||||||
intangible assets | 95,806,000 | 99,094,000 | 102,301,000 | 108,873,000 | 112,532,000 | 116,348,000 | 88,593,000 | 123,567,000 | 164,744,000 | 170,226,000 | 174,866,000 | 176,542,000 | 184,367,000 | 196,228,000 | 202,731,000 | 209,521,000 | 155,700,000 | 159,423,000 | ||||||||||||||||||||||||||
goodwill | 773,255,000 | 754,272,000 | 745,800,000 | 762,117,000 | 752,107,000 | 753,853,000 | 702,984,000 | 693,176,000 | 698,920,000 | 699,718,000 | 695,891,000 | 676,885,000 | 690,040,000 | 704,368,000 | 707,904,000 | 714,273,000 | 471,764,000 | 474,838,000 | 2,725,000 | 2,725,000 | 2,725,000 | 2,725,000 | 2,725,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | 1,057,000 | |||
restricted cash | 1,654,000 | 1,645,000 | 1,544,000 | 1,080,000 | 1,088,000 | 1,082,000 | 876,000 | 870,000 | 889,000 | 749,000 | 749,000 | 749,000 | 749,000 | 749,000 | 749,000 | 749,000 | 749,000 | 749,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 603,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 238,000 | 118,000 | 118,000 | 118,000 | 118,000 | 118,000 | |||
other assets | 1,477,000 | 7,095,000 | 6,981,000 | 7,872,000 | 7,087,000 | 5,639,000 | 5,971,000 | 5,582,000 | 6,116,000 | 5,543,000 | 5,418,000 | 2,143,000 | 1,993,000 | 1,799,000 | 2,198,000 | 1,636,000 | 1,504,000 | 2,286,000 | 1,399,000 | 2,303,000 | 1,271,000 | 1,302,000 | 1,437,000 | 1,228,000 | 1,061,000 | 1,049,000 | 1,086,000 | 837,000 | 598,000 | 466,000 | 326,000 | 178,000 | 134,000 | 127,000 | 134,000 | 203,000 | 172,000 | 208,000 | 195,000 | 185,000 | 180,000 | 142,000 | 145,000 | 157,000 |
total assets | 1,344,104,000 | 1,315,411,000 | 1,300,035,000 | 1,275,021,000 | 1,234,327,000 | 1,200,073,000 | 1,114,906,000 | 1,124,943,000 | 1,161,114,000 | 1,157,119,000 | 1,156,422,000 | 1,125,957,000 | 1,144,198,000 | 1,173,589,000 | 1,187,825,000 | 1,186,356,000 | 1,027,435,000 | 1,025,136,000 | 457,163,000 | 454,151,000 | 256,737,000 | 267,100,000 | 275,212,000 | 260,307,000 | 252,377,000 | 123,537,000 | 120,638,000 | 119,077,000 | 65,461,000 | 71,190,000 | 78,669,000 | 83,659,000 | 88,347,000 | 92,606,000 | 101,034,000 | 69,650,000 | 74,832,000 | 84,267,000 | 80,853,000 | 82,503,000 | 55,060,000 | 67,750,000 | 72,454,000 | 23,571,000 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 11,447,000 | 15,709,000 | 8,634,000 | 9,670,000 | 12,084,000 | 12,152,000 | 12,943,000 | 12,531,000 | 12,895,000 | 15,655,000 | 11,911,000 | 11,114,000 | 10,328,000 | 11,273,000 | 12,360,000 | 11,201,000 | 8,472,000 | 7,137,000 | 3,116,000 | 1,932,000 | 2,224,000 | 7,665,000 | 2,328,000 | 5,568,000 | 4,061,000 | 4,064,000 | 2,516,000 | 1,175,000 | 1,962,000 | 3,356,000 | 3,853,000 | 3,161,000 | 2,349,000 | 2,611,000 | 2,424,000 | 3,081,000 | 2,705,000 | 4,340,000 | 6,644,000 | 2,688,000 | 6,854,000 | 8,539,000 | 7,214,000 | 5,604,000 |
accrued liabilities | 43,707,000 | 35,928,000 | 43,826,000 | 43,872,000 | 43,455,000 | 30,293,000 | 38,427,000 | 34,828,000 | 34,427,000 | 30,641,000 | 37,774,000 | 32,137,000 | 33,565,000 | 38,543,000 | 39,475,000 | 29,044,000 | 20,756,000 | 16,254,000 | 11,705,000 | 10,445,000 | 9,386,000 | 10,079,000 | 13,734,000 | 9,760,000 | 9,820,000 | 8,788,000 | 9,186,000 | 9,261,000 | 8,429,000 | 8,483,000 | 8,175,000 | 8,058,000 | 8,450,000 | 6,800,000 | 9,110,000 | 7,189,000 | 8,910,000 | 7,021,000 | 7,365,000 | 7,217,000 | 5,396,000 | 5,128,000 | 5,267,000 | 4,416,000 |
current portion of deferred revenue | 1,450,000 | 1,712,000 | 1,673,000 | 2,033,000 | 2,195,000 | 2,602,000 | 2,008,000 | 2,214,000 | 2,378,000 | 2,194,000 | 2,613,000 | 3,863,000 | 4,193,000 | 4,878,000 | 4,646,000 | 3,440,000 | 566,000 | 454,000 | 371,000 | |||||||||||||||||||||||||
current portion of acquisition-related contingent consideration | 13,415,000 | 14,360,000 | 16,981,000 | 7,391,000 | 7,348,000 | 6,934,000 | 2,657,000 | 2,574,000 | 3,359,000 | 3,300,000 | 6,060,000 | 5,913,000 | 5,998,000 | 2,703,000 | 2,682,000 | 2,646,000 | 3,375,000 | |||||||||||||||||||||||||||
current portion of operating lease liabilities | 6,414,000 | 7,409,000 | 7,500,000 | 7,294,000 | 7,185,000 | 5,982,000 | 5,105,000 | 5,007,000 | 4,973,000 | 4,076,000 | 4,070,000 | 3,958,000 | 3,930,000 | 3,849,000 | 3,630,000 | |||||||||||||||||||||||||||||
current portion of other liabilities | 7,000 | 19,000 | 53,000 | 72,000 | 89,000 | 101,000 | 106,000 | 119,000 | 127,000 | 186,000 | 180,000 | 198,000 | 218,000 | 231,000 | 241,000 | |||||||||||||||||||||||||||||
total current liabilities | 76,433,000 | 75,125,000 | 78,633,000 | 70,313,000 | 72,339,000 | 58,052,000 | 61,241,000 | 57,260,000 | 58,151,000 | 55,993,000 | 62,614,000 | 58,352,000 | 59,345,000 | 62,543,000 | 64,151,000 | 50,037,000 | 36,105,000 | 32,709,000 | 16,781,000 | 13,919,000 | 13,105,000 | 19,194,000 | 17,469,000 | 16,772,000 | 15,321,000 | 14,329,000 | 13,059,000 | 10,436,000 | 10,391,000 | 11,839,000 | 12,028,000 | 11,219,000 | 10,799,000 | 9,411,000 | 11,534,000 | 10,270,000 | 11,842,000 | 11,879,000 | 15,432,000 | 11,802,000 | 14,147,000 | 17,107,000 | 15,448,000 | 12,520,000 |
deferred tax liabilities | 1,301,000 | 1,242,000 | 1,470,000 | 1,483,000 | 1,340,000 | 3,644,000 | 4,707,000 | 4,594,000 | 4,342,000 | 4,605,000 | 4,983,000 | |||||||||||||||||||||||||||||||||
acquisition-related contingent consideration, net of current portion | 573,000 | 570,000 | 561,000 | 14,225,000 | 13,889,000 | 13,446,000 | 518,000 | 484,000 | 4,855,000 | 4,773,000 | 2,498,000 | 2,411,000 | 2,358,000 | 5,732,000 | 5,722,000 | 5,251,000 | 4,467,000 | 1,800,000 | ||||||||||||||||||||||||||
operating lease liabilities, net of current portion | 44,232,000 | 43,092,000 | 43,237,000 | 12,400,000 | 13,553,000 | 8,058,000 | 7,525,000 | 8,720,000 | 9,891,000 | 9,709,000 | 10,648,000 | 11,527,000 | 12,529,000 | 13,485,000 | 14,096,000 | |||||||||||||||||||||||||||||
other liabilities | 508,000 | 446,000 | 411,000 | 571,000 | 540,000 | 528,000 | 786,000 | 776,000 | 792,000 | 791,000 | 931,000 | 1,148,000 | 1,210,000 | 1,378,000 | 1,407,000 | 1,891,000 | ||||||||||||||||||||||||||||
total liabilities | 123,047,000 | 120,475,000 | 124,069,000 | 98,979,000 | 101,804,000 | 81,424,000 | 70,804,000 | 70,884,000 | 78,396,000 | 75,860,000 | 81,222,000 | 77,780,000 | 80,047,000 | 88,399,000 | 91,311,000 | 79,276,000 | 56,258,000 | 50,905,000 | 35,931,000 | 31,426,000 | 30,590,000 | 36,678,000 | 35,757,000 | 29,283,000 | 28,137,000 | 39,765,000 | 40,883,000 | 39,660,000 | 39,655,000 | 41,182,000 | 41,444,000 | 40,843,000 | 40,503,000 | 39,256,000 | 41,453,000 | 39,645,000 | 41,079,000 | 40,961,000 | 23,042,000 | 17,415,000 | 19,981,000 | 22,725,000 | 22,164,000 | 21,124,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
common stock | 79,000 | 78,000 | 78,000 | 77,000 | 77,000 | 76,000 | 73,000 | 73,000 | 73,000 | 72,000 | 72,000 | 72,000 | 72,000 | 71,000 | 71,000 | 71,000 | 67,000 | 67,000 | 58,000 | 58,000 | 50,000 | 50,000 | 50,000 | 49,000 | 48,000 | 42,000 | 41,000 | 41,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 34,000 | 28,000 | 28,000 | 28,000 | 27,000 | 27,000 | 23,000 | 21,000 | 21,000 | 1,000 |
additional paid-in capital | 1,670,853,000 | 1,660,435,000 | 1,655,961,000 | 1,646,343,000 | 1,627,307,000 | 1,617,465,000 | 1,536,168,000 | 1,528,011,000 | 1,520,638,000 | 1,509,861,000 | 1,500,191,000 | 1,492,044,000 | 1,483,279,000 | 1,477,418,000 | 1,468,683,000 | 1,461,778,000 | 1,303,610,000 | 1,297,626,000 | 702,768,000 | 696,217,000 | 495,523,000 | 488,773,000 | 486,090,000 | 470,202,000 | 462,689,000 | 319,733,000 | 313,800,000 | 310,357,000 | 252,284,000 | 250,238,000 | 248,278,000 | 245,430,000 | 243,409,000 | 241,617,000 | 239,631,000 | 205,658,000 | 203,769,000 | 202,079,000 | 198,497,000 | 196,829,000 | 157,688,000 | 143,982,000 | 142,592,000 | 3,181,000 |
accumulated deficit | -437,916,000 | -436,936,000 | -443,983,000 | -449,096,000 | -464,251,000 | -469,985,000 | -468,121,000 | -439,828,000 | -410,210,000 | -401,808,000 | -393,717,000 | -389,873,000 | -381,150,000 | -371,618,000 | -357,157,000 | -346,629,000 | -332,500,000 | -323,462,000 | -281,594,000 | -273,550,000 | -269,426,000 | -258,401,000 | -246,685,000 | -239,227,000 | -238,497,000 | -236,003,000 | -234,086,000 | -230,981,000 | -226,512,000 | -220,264,000 | -211,087,000 | -202,648,000 | -195,599,000 | -188,301,000 | -180,084,000 | -175,681,000 | -170,044,000 | |||||||
accumulated other comprehensive loss | -11,959,000 | -28,641,000 | -36,090,000 | -21,282,000 | -30,610,000 | -28,907,000 | -24,018,000 | -34,197,000 | -27,783,000 | -26,866,000 | -31,346,000 | -54,066,000 | -38,050,000 | -20,681,000 | -15,083,000 | -8,140,000 | ||||||||||||||||||||||||||||
total stockholders’ equity | 1,221,057,000 | 1,194,936,000 | 1,176,042,000 | 1,132,523,000 | 1,118,649,000 | 1,054,059,000 | 1,082,718,000 | 1,081,259,000 | 1,048,177,000 | 1,064,151,000 | 1,085,190,000 | 1,107,080,000 | 971,177,000 | 974,231,000 | 422,725,000 | 226,147,000 | 230,422,000 | 231,024,000 | 224,240,000 | 83,772,000 | 79,417,000 | 25,806,000 | 30,008,000 | 42,816,000 | 47,844,000 | 53,350,000 | 30,005,000 | 33,753,000 | 43,306,000 | 57,811,000 | 65,088,000 | 35,079,000 | 45,025,000 | 50,290,000 | ||||||||||
total liabilities and stockholders’ equity | 1,344,104,000 | 1,315,411,000 | 1,275,021,000 | 1,234,327,000 | 1,200,073,000 | 1,124,943,000 | 1,161,114,000 | 1,157,119,000 | 1,125,957,000 | 1,144,198,000 | 1,173,589,000 | 1,186,356,000 | 1,027,435,000 | 1,025,136,000 | 454,151,000 | 256,737,000 | 267,100,000 | 260,307,000 | 252,377,000 | 123,537,000 | 119,077,000 | 65,461,000 | 71,190,000 | 83,659,000 | 88,347,000 | 92,606,000 | 69,650,000 | 74,832,000 | 84,267,000 | 80,853,000 | 82,503,000 | 55,060,000 | 67,750,000 | 72,454,000 | ||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||
deferred tax liability | 1,227,000 | 734,000 | 4,531,000 | 5,592,000 | 6,234,000 | 773,000 | 750,000 | 222,000 | 254,000 | 300,000 | ||||||||||||||||||||||||||||||||||
stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2024 and 2023 | ||||||||||||||||||||||||||||||||||||||||||||
total stockholders' equity | 1,175,966,000 | 1,044,102,000 | 1,075,200,000 | 1,096,514,000 | 421,232,000 | 239,455,000 | 79,755,000 | 37,225,000 | 59,581,000 | |||||||||||||||||||||||||||||||||||
total liabilities and stockholders' equity | 1,300,035,000 | 1,114,906,000 | 1,156,422,000 | 1,187,825,000 | 457,163,000 | 275,212,000 | 120,638,000 | 78,669,000 | 101,034,000 | |||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2023 and 2022 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
property and equipment | 17,702,000 | 17,237,000 | 17,188,000 | 16,299,000 | 15,098,000 | 14,868,000 | 11,813,000 | 10,562,000 | 8,990,000 | 8,914,000 | 8,640,000 | 8,788,000 | 8,933,000 | 8,488,000 | 8,150,000 | 8,114,000 | 8,940,000 | 8,939,000 | 9,035,000 | 9,215,000 | 9,688,000 | 10,281,000 | 10,093,000 | 10,657,000 | 11,480,000 | 10,435,000 | 10,937,000 | 11,272,000 | 6,200,000 | 4,211,000 | 4,132,000 | 3,312,000 | 3,028,000 | 2,826,000 | ||||||||||
right-of-use assets - operating leases | 13,160,000 | 16,043,000 | ||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 1,187,000 | 1,133,000 | 1,079,000 | 1,127,000 | 1,357,000 | 940,000 | 467,000 | |||||||||||||||||||||||||||||||||||||
deferred revenue, net of current portion | 278,000 | 343,000 | 552,000 | 662,000 | 747,000 | 829,000 | ||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2022 and 2021 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
supplies | 11,225,000 | 9,824,000 | 6,674,000 | 6,308,000 | 4,657,000 | 4,456,000 | 7,041,000 | 6,094,000 | 6,806,000 | 6,608,000 | 5,104,000 | 3,768,000 | 3,402,000 | 3,463,000 | ||||||||||||||||||||||||||||||
long-term debt | 1,075,000 | 917,000 | 863,000 | 810,000 | 756,000 | 801,000 | 748,000 | 694,000 | 639,000 | 585,000 | 12,854,000 | 23,925,000 | 25,192,000 | 25,103,000 | 25,016,000 | 24,938,000 | 24,997,000 | 24,971,000 | 24,944,000 | 24,918,000 | 24,891,000 | 24,671,000 | 24,452,000 | 5,002,000 | 4,975,000 | 4,949,000 | ||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2021 and 2020 | ||||||||||||||||||||||||||||||||||||||||||||
right-of-use assets, operating lease | 16,001,000 | 14,559,000 | ||||||||||||||||||||||||||||||||||||||||||
current portion of operating lease liability | 3,465,000 | 2,936,000 | 2,878,000 | 1,589,000 | 1,542,000 | 1,495,000 | 1,450,000 | 1,407,000 | 1,365,000 | 1,284,000 | 1,244,000 | |||||||||||||||||||||||||||||||||
operating lease liability, net of current portion | 14,236,000 | 13,334,000 | 14,036,000 | 9,917,000 | 10,331,000 | 10,736,000 | 11,132,000 | 11,506,000 | 11,872,000 | 12,231,000 | 12,582,000 | |||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding as of september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding as of june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
right-of-use assets - operating lease | 15,186,000 | 7,843,000 | 8,094,000 | 8,339,000 | 8,576,000 | 8,808,000 | 9,033,000 | 9,412,000 | 9,630,000 | |||||||||||||||||||||||||||||||||||
current portion of acquisition related contingent consideration | 5,986,000 | |||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding as of march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
finite-lived intangible assets | 59,924,000 | 61,197,000 | 62,471,000 | 63,744,000 | 65,019,000 | 11,200,000 | 11,467,000 | 11,733,000 | 12,000,000 | 12,267,000 | 12,533,000 | 12,800,000 | 13,067,000 | 13,333,000 | 13,600,000 | 13,867,000 | 14,133,000 | 14,400,000 | 14,666,000 | 14,933,000 | 15,467,000 | 15,733,000 | ||||||||||||||||||||||
acquisition related contingent consideration | 7,594,000 | 6,088,000 | ||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2020 and 2019 | ||||||||||||||||||||||||||||||||||||||||||||
acquisition-related contingent consideration | 6,420,000 | 5,948,000 | 5,604,000 | |||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
deferred rent, net of current portion | 3,899,000 | 3,953,000 | 4,005,000 | 4,094,000 | 4,170,000 | 4,245,000 | 4,277,000 | 4,373,000 | 4,402,000 | 4,484,000 | 4,566,000 | 4,630,000 | 2,386,000 | 384,000 | 111,000 | 223,000 | 260,000 | 250,000 | ||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2019 and 2018 | ||||||||||||||||||||||||||||||||||||||||||||
right-of-use assets - finance lease | 619,000 | 677,000 | 735,000 | |||||||||||||||||||||||||||||||||||||||||
current portion of finance lease liability | 79,000 | 156,000 | 233,000 | |||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
capital lease liability, net of current portion | 79,000 | 156,000 | 233,000 | 308,000 | 382,000 | 456,000 | 528,000 | 599,000 | ||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2018 and 2017 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||
supplies inventory | 3,049,000 | 4,557,000 | 5,324,000 | 3,760,000 | 3,317,000 | 3,443,000 | 3,475,000 | 3,416,000 | 3,502,000 | 3,652,000 | 3,984,000 | 3,976,000 | 3,732,000 | 3,300,000 | 2,721,000 | 1,392,000 | ||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2017 and 2016 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||
deferred genzyme co-promotion fee | 227,000 | 518,000 | 1,423,000 | 1,897,000 | 1,897,000 | 2,500,000 | 2,500,000 | 2,500,000 | ||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of december 31, 2016 and 2015 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||||||
deferred tax asset | 222,000 | 254,000 | 300,000 | |||||||||||||||||||||||||||||||||||||||||
indefinite-lived intangible assets: in-process research and development | ||||||||||||||||||||||||||||||||||||||||||||
deferred genzyme co-promotion fee, net of current portion | 474,000 | 1,364,000 | 1,989,000 | 3,239,000 | ||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of september 30, 2015 and december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of june 30, 2015 and december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||||||
in-process research and development | 16,000,000 | |||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of march 31, 2015 and december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||||||
long-term debt, net of current portion | 4,031,000 | 4,467,000 | ||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding as of june 30, 2014 and december 31, 2013, respectively | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding as of march 31, 2014 and december 31, 2013, respectively | ||||||||||||||||||||||||||||||||||||||||||||
liabilities, convertible preferred stock, and stockholders’ (deficit) equity | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock liability | ||||||||||||||||||||||||||||||||||||||||||||
long-term debt, net of discount | 4,863,000 | |||||||||||||||||||||||||||||||||||||||||||
preferred stock warrant liability | 252,000 | |||||||||||||||||||||||||||||||||||||||||||
convertible preferred stock; 0.001 par value, 60,187,700 and 59,147,999 shares authorized at september 30, 2013 (unaudited) and december 31, 2012, respectively; 59,989,268 and 53,084,507 shares issued and outstanding at september 30, 2013 (unaudited) and december 31, 2012, respectively | 79,022,000 | |||||||||||||||||||||||||||||||||||||||||||
stockholders’ (deficit) equity: | ||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ (deficit) equity | ||||||||||||||||||||||||||||||||||||||||||||
total liabilities, convertible preferred stock, and stockholders’ (deficit) equity | 23,571,000 |
We provide you with 20 years of balance sheets for Veracyte stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Veracyte. Explore the full financial landscape of Veracyte stock with our expertly curated balance sheets.
The information provided in this report about Veracyte stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.